Endothelial progenitor cells express PAF receptor and respond to PAF via Ca2+-dependent signaling

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1801, Issue 10, 2010, Pages 1123-1132

  Balestrieri, Maria Luisa ^a   Giovane, Alfonso ^a   Milone, Lara ^a   Servillo, Luigi ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Endothelial progenitor cells; Inflammation; PAF

Indexed keywords

[2 METHOXY 3 (N OCTADECYLCARBAMOYLOXY)PROPYL] (2 THIAZOLIOETHYL) PHOSPHATE; GLUCOSE; SYNAPTOPHYSIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR DERIVATIVE;

ARTICLE; CELL COUNT; CELL GROWTH; CELL THERAPY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STEM CELL;

CALCIUM; CALCIUM SIGNALING; CELL COUNT; CELL SURVIVAL; CYTOPLASM; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; INTRACELLULAR SPACE; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, G-PROTEIN-COUPLED; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955516608     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2010.07.001     Document Type: Article

References (48)

1. Napoli C., Maione C., Schiano C., Fiorito C., Ignarro L.J. Bone marrow cell-mediated cardiovascular repair: potential of combined therapies. Trends Mol. Med. 2007, 13:278-286.
2. Shantsila F., Watson T., Lip G.Y. Endothelial progenitor cells in cardiovascular disorders. J. Am. Coll. Cardiol. 2007, 49:741-752.
3. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., Li T., Isner J.M., Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularisation. Proc. Natl Acad. Sci. USA 2000, 97:3422-3427.
4. Iwaguro H., Yamaguchi J., Kalka C., Murasawa S., Masuda H., Hayashi S., Silver M., Li T., Isner J.M., Asahara T. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002, 105:732-738.
5. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., Kearne M., Magner M., Isner J.M. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 1999, 85:221-228.
6. Balestrieri M.L., Lu S.J., de Nigris F., Giovane A., Williams-Ignarro S., D'Armiento F.P., Feng Q., Fiorito C., Testa G., Pastore L., Cacciatore F., Mancini F.P., Servillo L., De Rosa G., Pagliarulo C., Rienzo M., Minucci P.B., Farzati B., Salvatore F., Rengo F., Ignarro L.J., Giordano A., Baker A., Lanza R., Napoli C. Therapeutic angiogenesis in diabetic apolipoprotein E-deficient mice using bone marrow cells, functional hemangioblasts and metabolic intervention. Atherosclerosis 2010, 209:403-414.
7. Assmus B., Schachinger V., Teupe C., Britten M., Lehmann R., Dobert N., Grunwald F., Aicher A., Urbich C., Martin H., Hoelzer D., Dimmeler S., Zeiher A.M. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction. Circulation 2002, 106:3009-3017.
8. Assmus B., Honold J., Schächinger V., Britten M.B., Fischer-Rasokat U., Lehmann R., Teupe C., Pistorius K., Martin H., Abolmaali N.D., Tonn T., Dimmeler S., Zeiher A.M. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J. Med. 2006, 355:1222-1232.
9. Meyer G.P., Wollert K.C., Lotz J., Steffens J., Lippolt P., Fichtner S., Hecker H., Schaefer A., Arseniev L., Hertenstein B., Ganser A., Drexler H. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006, 113:1287-1294.
10. Tateishi-Yuyama E., Matsubara H., Murohara T., Ikeda U., Shintani S., Masaki H., Amano K., Kishimoto Y., Yoshimoto K., Akashi H., Shimada K., Iwasaka T., Imaizumi T. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002, 360:427-435.
11. Timmermans F., Plum J., Yöder M.C., Ingram D.A., Vandekerckhove B., Case J. Endothelial progenitor cells: identity defined?. J. Cell. Mol. Med. 2009, 13:87-102.
12. Critser P.J., Yoder M.C. Endothelial colony-forming cell role in neoangiogenesis and tissue repair. Curr. Opin. Organ. 2010, 15:68-72.
13. Hirschi K.K., Ingram D.A., Yoder M.C. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1584-1595.
14. Sieveking D.P., Buckle A., Celermajer D.S., Ng M.K. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J. Am. Coll. Cardiol. 2008, 51:660-668.
15. Güven H., Shepherd R.M., Bach R.G., Capoccia B.J., Link D.C. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J. Am. Coll. Cardiol. 2006, 48:1579-1587.
16. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J. Med. 2003, 348:593-600.
17. Zhang Y., Ingram D.A., Murphy M.P., Saadatzadeh M.R., Mead L.E., Prater D.N., Rehman J. Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H1675-H1682.
18. Zhang Y., Herbert B.S., Rajashekhar G., Ingram D.A., Yoder M.C., Clauss M., Rehman J. Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-alpha via the p38 mitogen-activated protein kinase pathway. FASEB J. 2009, 23:1358-1365.
19. Seeger F.H., Haendeler J., Walter D.H., Rochwalsky U., Reinhold J., Urbich C., Rossig L., Corbaz A., Chvatchko Y., Zeiher A.M., Dimmeler S. p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 2005, 111:1184-1191.
20. Balestrieri M.L., Schiano C., Felice F., Casamassimi A., Balestrieri A., Milone L., Servillo L., Napoli C. Effect of low doses of red wine and pure resveratrol on circulating endothelial progenitor cells. J. Biochem. 2008, 143:179-186.
21. Balestrieri M.L., Rienzo M., Felice F., Rossiello R., Grimaldi V., Milone L., Casamassimi A., Servillo L., Farzati B., Giovane A., Napoli C. High glucose downregulates endothelial progenitor cell number via SIRT1. Biochim. Biophys. Acta 2008, 1784:936-945.
22. Fadini G.P., Miorin M., Facco M., Bonamico S., Baesso I., Grego F., Menegolo M., de Kreutzenberg S.V., Tiengo A., Agostini C., Avogaro A. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J. Am. Coll. Cardiol. 2005, 45:1449-1457.
23. Loomans C.J., de Koning E.J., Staal F.J., Rookmaaker M.B., Verseyden C., de Boer H.C., Verhaar M.C., Braam B., Rabelink T.J., van Zonneveld A.J. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004, 53:195-199.
24. Fadini G.P., Boscaro E., de Kreutzenberg S., Agostini C., Seeger F., Dimmeler S., Zeiher A., Tiengo A., Avogaro A. Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes mellitus. Diab. Care 2010, 33:1097-1102.
25. Shimizu T. Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu. Rev. Pharmacol. Toxicol. 2009, 49:123-150.
26. Montrucchio G., Alloatti G., Camussi G. Role of platelet-activating factor in cardiovascular pathophysiology. Physiol. Rev. 2000, 80:1669-1699.
27. Honda Z., Nakamura M., Miki I., Minami M., Watanabe T., Seyama Y., Okado H., Toh H., Ito K., Miyamoto T., et al. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature 1991, 349:342-346.
28. Servillo L., Balestrieri C., Giovane A., Pari P., Palma D., Giannattasio G., Triggiani M., Balestrieri M.L. Lysophospholipid transacetylase in the regulation of PAF levels in human monocytes and macrophages. FASEB J. 2006, 20:1015-1017.
29. Bae K., Longobardi L., Karasawa K., Malone B., Inoue T., Akoi J., Arai H., Inoue K., Lee T-c. Platelet activating factor (PAF)-dependent transacetylase and its relationship with PAF acetylhydrolases. J. Biol. Chem. 2000, 275:26704-26709.
30. Tsoukatos D.C., Brochériou I., Moussis V., Panopoulou C.P., Christofidou E.D., Koussissis S., Sismanidis S., Ninio E., Siminelakis S. Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery. J. Lipid Res. 2008, 49:2240-2249.
31. Rastogi P., White M.C., Rickard A., McHowat J. Potential mechanism for recruitment and migration of CD133 positive cells to areas of vascular inflammation. Thromb. Res. 2008, 123:258-266.
32. Casamassimi A., Balestrieri M.L., Fiorito C., Schiano C., Maione C., Rossiello R., Grimaldi V., Del Giudice V., Balestrieri C., Farzati B., Sica V., Napoli C. Comparison between total endothelial progenitor cell isolation versus enriched Cd133+ culture. J. Biochem. 2007, 141:503-511.
33. Bligh E.G., Dyer W.T. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 1959, 261:911-917.
34. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
35. Ishii S., Shimizu T. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog. Lipid Res. 2000, 39:41-82.
36. Wu Y., Wang Q., Cheng L., Wang J., Lu G. Effect of oxidized low-density lipoprotein on survival and function of endothelial progenitor cell mediated by p38 signal pathway. J. Cardiovasc. Pharmacol. 2009, 53:151-156.
37. Kuki S., Imanishi T., Kobayashi K., Matsuo Y., Obana M., Akasaka T. Hyperglycemia accelerated endothelial progenitor cell senescence via the activation of p38 mitogen-activated protein kinase. Circ. J. 2006, 70:1076-1081.
38. Libby P., Theroux P. Pathophysiology of coronary artery disease. Circulation 2005, 111:3481-3488.
39. Awad O., Dedkov E.I., Jiao C., Bloomer S., Tomanek R.J., Schatteman G.C. Differential healing activities of CD34+ and CD14+ endothelial cell progenitors. Arterioscler. Thromb. Vasc. Biol. 2006, 26:758-764.
40. Rehman J., Li J., Orschell C.M., March K.L. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003, 107:1164-1169.
41. Korth R.M., Hirafuji M., Benveniste J., Russo-Marie F. Human umbilical vein endothelial cells: specific binding of platelet-activating factor and cytosolic calcium flux. Biochem. Pharmacol. 1995, 49:1793-1799.
42. Denizot Y., Dupuis F., Trimoreau F., Verger C., Allegraud A., Praloran V. PAF and haematopoiesis: IX. Platelet-activating factor increases DNA synthesis in human bone marrow cells. J. Lipid Mediat. Cell Signal. 1996, 15:1-4.
43. Zhao D., Chu W.F., Wu L., Li J., Liu Q.M., Lu Y.J., Qiao G.F., Wang Z.G., Zhang Z.R., Yang B.F. PAF exerts a direct apoptotic effect on the rat H9c2 cardiomyocytes in Ca(2+)-dependent manner. Int. J. Cardiol. 2009, Feb 21. [Epub ahead of print].
44. Yang S.H., Sharrocks A.D., Whitmarsh A.J. Transcriptional regulation by the MAP kinase signaling cascades. Gene 2003, 320:3-21.
45. Kumar S., Boehm J., Lee J.C. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov. 2003, 2:717-726.
46. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A.M., Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 2001, 89:e1-e7.
47. Tepper O.M., Galiano R.D., Capla J.M., Kalka C., Gagne P.J., Jacobowitz G.R., Levine J.P., Gurtner G.C. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002, 106:2781-2786.
48. Ninio E. Phospholipid mediators in the vessel wall: involvement in atherosclerosis. Curr. Opin. Clin. Nutr. Metab. Care 2005, 8:123-131.